COMMUNIQUÉS West-GlobeNewswire

-
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
25/06/2024 - 21:30 -
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
25/06/2024 - 20:43 -
SAFE - Finalisation des plans de redressement - Reports de l’Assemblée Générale annuelle 2024 et de la publication du rapport financier annuel 2023
25/06/2024 - 19:57 -
Press Release: Availability of the Q2 2024 Aide-mémoire
25/06/2024 - 19:32 -
Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 »
25/06/2024 - 19:32 -
HFMA Announces Marc Scher as National Chair
25/06/2024 - 18:30 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024
25/06/2024 - 18:00 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2024
25/06/2024 - 18:00 -
Higher cantonal composition authority approved the amendments to the terms of the 2024 convertible bonds
25/06/2024 - 17:45 -
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
25/06/2024 - 17:02 -
CORRECTION: Capricor Therapeutics
25/06/2024 - 16:30 -
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
25/06/2024 - 16:24 -
Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
25/06/2024 - 16:23 -
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
25/06/2024 - 16:00 -
MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023
25/06/2024 - 15:37 -
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
25/06/2024 - 15:31 -
Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance
25/06/2024 - 15:20 -
InkSpace Imaging Broadens Body Array Access Across GE HealthCare 3T MRI Systems
25/06/2024 - 15:00 -
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
25/06/2024 - 15:00
Pages